Save after changing Favorites. Use Share Link when you want the same list on another device.
Your link (Favorites):
All Favorites
#
Name
Description
Category
Type
Source
Website
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Formoterol und Fluticason, ATC R03AK11
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineMar 5, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Somatropin, ATC H01AC01
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineMar 5, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Formoterol und Aclidiniumbromid, ATC R03AL05
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineMar 5, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Vilanterol und Fluticasonfuroat, ATC R03AK10
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineMar 5, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Pimecrolimus, ATC D11AH02 für die Zeit 01.05.2025 - 30.04.2027
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Fertigarzneimittel SMOFkabiven, ATC B05BA10 für die Zeit 01.05.2025 - 30.04.2027
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Interferon beta-1a (ausschl. z. intramuskulären Injektion), ATC L03AB07 für die Zeit 01.05.2025 - 30.04.2027
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Formoterol + Aclidiniumbromid, ATC R03AL05 für die Zeit 01.05.2025 - 30.04.2027
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tamsulosin + Solifenacin, ATC G04CA53 für die Zeit 01.05.2025 - 30.04.2027
Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2025-03
ted.europa.eu
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineMar 5, 2027
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Dupilumab, ATC D11AH05 für die Zeit 01.05.2025 - 30.04.2027
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Peginterferon beta-1a, ATC L03AB13 für die Zeit 01.05.2025 - 30.04.2027
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach §130a Abs.8 SGB V zu verschiedenen Wirkstoff-/en/-kombinationen mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open House-Verfahrens
ted.europa.eu
Buyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineMar 5, 2027
Buyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05
GRA
High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)
grants.gov
The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA...
GrantCash GrantUnited StatesOpen
AmountNot provided on the source page. Please check the official source.
DeadlineMar 6, 2027
The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. This FOA is open to both individual researchers and research teams and includes all areas of research from basic science to clinical and implementation research. All studies must focus on NIH HIV/AIDS Research Priorities: NOT-OD-20-018: UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding.
GRA
Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional)
grants.gov
The goal of this program is to support collaborative translational research projects aligned with NIH efforts to enhance the translation of basic biol...
GrantMixedUnited StatesOpen
AmountAward ceiling: $500,000
DeadlineMar 6, 2027
The goal of this program is to support collaborative translational research projects aligned with NIH efforts to enhance the translation of basic biological discoveries into clinical applications that improve health. It encourages high quality science demonstrating the potential to result in understanding an important disease process or lead to new therapeutic interventions, diagnostics, or prevention strategies within the research interests and priorities of the participating NIH Institutes/Centers (ICs).Specifically, the program seeks to broaden and strengthen translational research collaborations between basic and clinical researchers both within and outside NIH to accelerate and enhance translational science by promoting partnerships between NIH intramural investigators (e.g., those conducting research within the labs and clinics of the NIH) and extramural investigators (e.g., those conducting research in labs outside the NIH), and by providing support for extramural investigators...
TEN
Lithuania – Engineering design services – (PU-12091/24) Susisiekimo komunikacijų projektavimo ir projekto vykdymo priežiūros paslaugos
Spain – Architectural and related services – Contratación de servicios de asistencia técnica facultativa relacionadas con las obras del Servicio Canario de la Salud, mediante el establecimiento de un sistema dinámico de adquisición.
ted.europa.eu
Buyer: [SCS] Dirección General de Recursos Económicos del Servicio Canario de la Salud | Notice type: cn-standard | Procedure: restricted | Contract:...
TenderProcurement ContractSpainOpen
AmountNot provided on the source page. Please check the official source.
DeadlineMar 9, 2027
Buyer: [SCS] Dirección General de Recursos Económicos del Servicio Canario de la Salud | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-03-09
GRA
Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
grants.gov
The NIH Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D) was created to improve research on type 1 diabetes (T1D) and cardiovascular disease (...
GrantMixedUnited StatesOpen
AmountAward ceiling: $500,000
DeadlineMar 10, 2027
The NIH Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D) was created to improve research on type 1 diabetes (T1D) and cardiovascular disease (CVD). Cardiovascular complications remain the top cause of death among people with T1D and greatly shorten lifespan. The mechanisms underlying atherosclerosis, cardiomyopathy, endothelial dysfunction, and cardiac autonomic neuropathy in T1D remain poorly understood. While managing traditional risk factors—such as high blood glucose, high blood pressure, and elevated cholesterol lower cardiovascular risk, a significant residual risk remains even with optimal control. In addition to atherosclerosis, both diastolic and systolic diabetic cardiomyopathy play a major role in morbidity and mortality among these patients. Currently, no therapies are specifically approved to prevent or treat these common and severe cardiovascular issues in T1D. The purpose of this NOFO is to promote collaborative and interdisciplinary research aimed at enhancing t...
TEN
France – Motor vehicles – SAD pour la fourniture de véhicules
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach §130a Abs.8 SGB V zu verschiedenen Wirkstoff-/en/-kombinationen mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open House-VerfahrensBuyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05
39440
High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and sub...
Grant
Cash Grant
United States
Not provided on the source page. Please check the official source.
The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. This FOA is open to both individual researchers and research teams and includes all areas of research from basic science to clinical and implementation research. All studies must focus on NIH HIV/AIDS Research Priorities: NOT-OD-20-018: UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding.
39441
Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional)The goal of this program is to support collaborative translational research projects aligned with NIH efforts to enhance the trans...
The goal of this program is to support collaborative translational research projects aligned with NIH efforts to enhance the translation of basic biological discoveries into clinical applications that improve health. It encourages high quality science demonstrating the potential to result in understanding an important disease process or lead to new therapeutic interventions, diagnostics, or prevention strategies within the research interests and priorities of the participating NIH Institutes/Centers (ICs).Specifically, the program seeks to broaden and strengthen translational research collaborations between basic and clinical researchers both within and outside NIH to accelerate and enhance translational science by promoting partnerships between NIH intramural investigators (e.g., those conducting research within the labs and clinics of the NIH) and extramural investigators (e.g., those conducting research in labs outside the NIH), and by providing support for extramural investigators to take advantage of the unique research opportunities available at the NIH Clinical Center by conducting clinical research projects in collaboration with NIH intramural investigators.
39442
Lithuania – Engineering design services – (PU-12091/24) Susisiekimo komunikacijų projektavimo ir projekto vykdymo priežiūros paslaugosBuyer: AB „Kelių priežiūra“ | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-03-07
Tender
Procurement Contract
Lithuania
Not provided on the source page. Please check the official source.
NEA Arts and Artifacts International Indemnity Program 2, FY2027 (3/27)See the application guidelines and instructions at arts.gov for more information.
Spain – Architectural and related services – Contratación de servicios de asistencia técnica facultativa relacionadas con las obras del Servicio Canario de la Salud, mediante el establecimiento de un sistema dinámico de adquisición.Buyer: [SCS] Dirección General de Recursos Económicos del Servicio Canario de la Salud | Notice type: cn-standard | Procedure: res...
Tender
Procurement Contract
Spain
Not provided on the source page. Please check the official source.
Buyer: [SCS] Dirección General de Recursos Económicos del Servicio Canario de la Salud | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-03-09
39449
Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)The NIH Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D) was created to improve research on type 1 diabetes (T1D) and card...
The NIH Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D) was created to improve research on type 1 diabetes (T1D) and cardiovascular disease (CVD). Cardiovascular complications remain the top cause of death among people with T1D and greatly shorten lifespan. The mechanisms underlying atherosclerosis, cardiomyopathy, endothelial dysfunction, and cardiac autonomic neuropathy in T1D remain poorly understood. While managing traditional risk factors—such as high blood glucose, high blood pressure, and elevated cholesterol lower cardiovascular risk, a significant residual risk remains even with optimal control. In addition to atherosclerosis, both diastolic and systolic diabetic cardiomyopathy play a major role in morbidity and mortality among these patients. Currently, no therapies are specifically approved to prevent or treat these common and severe cardiovascular issues in T1D. The purpose of this NOFO is to promote collaborative and interdisciplinary research aimed at enhancing the understanding of the development of CVD in individuals with T1D and the differences with CVD in T1D by continuing the efforts of the CaRe-T1D consortium.This NOFO is associated with the Special Diabetes Program (https://www.niddk.nih.gov/about-niddk/research-areas/diabetes/type-1-diabetes-special-statutory-funding-program/about-special-diabetes-program) which funds research on the prevention, treatment, and cure of type 1 diabetes and its complications, including unique, innovative, and collaborative research consortia and clinical trials networks.
39450
France – Motor vehicles – SAD pour la fourniture de véhiculesBuyer: Institut Public Ocens | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-03-10
Tender
Procurement Contract
France
Not provided on the source page. Please check the official source.
